Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 05Th June, 2020.

Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2020 ,inter alia, to consider and approve (i) to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2020; and (ii) to consider and recommend Final Dividend, if any, for the financial year ended 31st March, 2020. Kindly take note of the same.
26-05-2020

Alkem Labs gets EIR from USFDA for St Louis facility in the US

The inspection was conducted by the USFDA from January 27, 2020 to February 6, 2020, Alkem Laboratories had said in an earlier filing.
12-05-2020
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

In furtherance to the intimation captioned "US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA" dated 07th February, 2020, this is to inform you that US FDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility and the inspection has now been closed by the US FDA. Kindly take the same on record.
12-05-2020
Bigul

Alkem Laboratories Ltd - 539523 - Compliances- Compliance Certificate For The Period Ended March, 2020.

With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance officer and the authorised representative of Link Intime India Pvt Ltd (RTA) for the half year ended 31st March, 2020. Kindly take the same on your records.
07-05-2020
Bigul

Alkem Laboratories Ltd - 539523 - Compliances - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2020.

In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary for the half year ended 31st March, 2020. Kindly take the same on record.
20-04-2020
Bigul

Alkem Laboratories Ltd - 539523 - Statement Of Investor Complaints For The Quarter Ended March 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Manish NarangDesignation :- Company Secretary and Compliance Officer
17-04-2020
Bigul

Alkem Laboratories Ltd - 539523 - Shareholding for the Period Ended March 31, 2020

Alkem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
16-04-2020
Bigul

Alkem Laboratories Ltd - 539523 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Alkem Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
06-04-2020
Bigul

Alkem Laboratories Ltd - 539523 - Details Of The Voting Results Of The Postal Ballot Process And Remote E-Voting - Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

In continuation of our letter dated 05th March, 2020 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the resolution as proposed in the Postal Ballot Notice dated 7th February, 2020 has been passed by the members of the Company with requisite majority. We are enclosing herewith the details regarding the voting results of the business transacted through Postal Ballot process (including Remote E-voting) in the prescribed format alongwith the Scrutinizer's Report. The same are also being uploaded on Company's website. The approval is deemed to have been received on the last date of receipt of postal ballot forms, i.e. on 04th April, 2020. Kindly take the same on record.
06-04-2020
Bigul

Alkem Laboratories Ltd - 539523 - Press Release - Alkem Contributes INR 7 Crores Towards Prime Minister'S Citizen Assistance And Relief In Emergency Situations (PM CARES) Fund

In light of the current COVID -19 crisis, the Company has contributed INR 7 Crores to the Prime Minister's Citizen Assistance and Relief in Emergency Situations (PMCARES) Fund in support to all on-going relief efforts. Enclosed herewith is the press release from Shri. Basudeo N. Singh, Executive Chairman of the Company.
30-03-2020
Next Page
Close

Let's Open Free Demat Account